Johns Hopkins University

Unlike most brain studies where scientists watch as people respond to cues or commands, Johns Hopkins researchers found a way to observe people’s brain activity as they made choices entirely on their own. 

A first-in-human prostate cancer study in the Journal of Molecular Imaging and Biology showed initial safety, biodistribution and dosimetry results with [18F]DCFPyL, a second-generation fluorine-18 labeled small-molecule prostate-specific membrane antigen (PSMA) inhibitor. The imaging biomarker has been developed at Johns Hopkins University in Baltimore by study co-author Martin G. Pomper, M.D., Ph.D.

Results of a Johns Hopkins study suggest magnetic resonance imaging (MRI) could one day make biopsies more effective or replace them altogether in determining if a tumor is or isn’t cancer. The MRI technique, so far tested only in test tube-grown cells and mice, is described in a report published March 27 in the online journal Nature Communications.

A 320-detector computed tomography (CT) scanner that shows both anatomy within coronary arteries and blood flow can accurately sort out which people need an invasive procedure to identify coronary blockages, according to an international study.

February 13, 2012 — Peake Healthcare Innovations, a joint venture between Harris Corporation and Johns Hopkins Medicine, announced a new approach to medical image management.